119th Congress
H.R. 1922
Ensuring Access to Essential Drugs Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Andrew R. Garbarino(R-NY)
- Introduced
- Mar 6, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (2)
Original cosponsors (2)
- Diana Harshbarger (R-TN)
- Thomas R. Suozzi (D-NY)
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Ensuring Access to Essential Drugs Act
This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.
Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 6, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Mar 6, 2025
Introduced in House